A detailed history of Maryland Capital Advisors Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Maryland Capital Advisors Inc. holds 2,820 shares of MRK stock, worth $280,449. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,820
Previous 2,820 -0.0%
Holding current value
$280,449
Previous $349,000 8.31%
% of portfolio
0.16%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

SELL
$102.95 - $114.33 $7,515 - $8,346
-73 Reduced 2.52%
2,820 $290,000
Q2 2022

Jul 25, 2022

SELL
$83.49 - $94.64 $3,089 - $3,501
-37 Reduced 1.26%
2,893 $264,000
Q1 2022

May 10, 2022

SELL
$73.51 - $82.4 $10,144 - $11,371
-138 Reduced 4.5%
2,930 $240,000
Q4 2021

Feb 01, 2022

BUY
$72.28 - $90.54 $221,755 - $277,776
3,068 New
3,068 $235,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Maryland Capital Advisors Inc. Portfolio

Follow Maryland Capital Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Advisors Inc. with notifications on news.